Wells Fargo & Company Bone Biologics Corp Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
About Bone Biologics Corp
- Ticker BBLG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,128,400
- Market Cap $18.8M
- Description
- Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for sp...